ATRA Clinical Trials
3 recruitingDrug
Not Applicable1Phase 21Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 3
Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).
APL
First Affiliated Hospital Xi'an Jiaotong University224 enrolled1 locationNCT07503730
Recruiting
Phase 2
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Relapsed Hodgkin LymphomaRefractory Hodgkin Lymphoma
Rita Assi24 enrolled2 locationsNCT06484920
Recruiting
Not Applicable
A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
First Affiliated Hospital of Zhejiang University29 enrolled1 locationNCT06371274